Breaking News

ICON Acquires BeijingWits

Adds China CRO capabilities

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

ICON has acquired BeijingWits Medical Consulting Ltd., a CRO in China. The transaction is expected to close in 1Q12. Financial terms of the deal were not disclosed. BeijingWits offers full-service clinical development capabilities, has expertise in Chinese regulatory processes and is a leading advocate of ICH GCP in China. In addition to boosting ICON’s service capabilities in the region, BeijingWits will also strengthen ICON’s presence through the addition of over 100 highly qualified and expe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters